Agoracom Blog Home

Posts Tagged ‘stocks’

AGORACOM Welcomes Marble Financial $MRBL.ca $MRBLF A #Fintech Company Utilizing the Power of #AI, Data Science and Machine Learning to Help Canadians Build and Manage Credit to Improve Their Financial Wellness $MOS.ca $MOGO.ca $CTZ.ca

Posted by AGORACOM at 11:33 AM on Monday, January 25th, 2021

(MRBL: CSE) (MRBLF: OTC) (2V0: FSE)

www.mymarble.ca

Why Marble?

  • Revolutionary fintech company utilizing the power of AI technology to help Canadians manage debt, build credit and budget.
  • Provides users:
    • Expert budgeting insights
    • Consumer proposal-exiting guidance
    • AI-powered credit boosting intelligence
    • Financial literacy
  • Robust B2B and B2C offerings.
  • A trusted fintech provider for businesses to maximize their customers credit profile.
  • Servicing a previously underserved subprime Canadian market
  • Strong Insiders/Management Ownership: 35%

What Exactly Does Marble Do?

‘MyMarble’ offers very specific, personalized financial recommendations about when to pay bills, how to prioritize debt management decisions and offers, tracks and highlights personalized data insights.

‘MyMarble’ through its suite of products offers innovative structured credit product solutions:

Screen-Shot-2021-01-22-at-3-44-59-PM

The MyMarble Ecosystem obtains leads from a number of tier one Canadian fintech companies which are funnelled accordingly due to a detailed needs analysis.

Screen-Shot-2021-01-22-at-3-46-41-PM

Did You Know 12 Million Canadians Are Below A Prime Credit Rating? credit

According to MNP (October 2020) , almost 50% of Canadians are living paycheque to paycheque and based on statistics from Statistics Canada’s Household Sector Credit Market Summary (June 2020), for every dollar of disposable income, Canadians carry a $1.77 of debt.  Additionally, Canada is a credit-based economy and financial literacy and good credit score is a major determinant to Financial Inclusion.

What Problem Does That Pose To Individuals Seeking Credit?

Screen-Shot-2021-01-22-at-3-41-01-PM

The Marble Model

marbl4

How Marble Acquires and Converts Customers

marble4

Screen-Shot-2021-01-22-at-2-06-21-PM

Benefits of This World Class, AI-Powered Platform:

  • Expert AI Insights and Real-Time Recommendations
    • Comprehensive monthly reporting provides expert insights to guide the best course of action to manage budgets effectively
  • Data-Driven Credit Score Improvement Solution
    • Marble’s Score-Up AI insights suggests steps which will make the biggest positive impact on credit scores using industry-leading monitoring and point deduction technology. 
    • In a recent Personal Finance Sentiments Survey conducted by Marble, approximately 70% of the respondents commented that they were embarrassed by their credit score, proving a willingness to improve their credit to an acceptable mainstream banking level.
    • In addition, a similar number of the same respondents identified having over $100 in disposable income each month, confirming Score-Up Lite’s affordability to people that could benefit from it. 
  • Specialist Curated Financial Literacy Platform
    • The company’s Maestro Financial Literacy education platform has been designed and developed by personal finance experts with decades of experience within the industry. 
  • Sustainable Consumer Proposal Exit solution
    • One of the only companies in Canada that specializes in exiting consumer proposals in a safe, fair and ethical way.

What Does The Company’s Financial Future Look Like?

marbl-6
marbl6
marble20

Hub On AGORACOM / Corporate Profile

Novamind $NM.ca to Present at Inaugural KCSA Psychedelics Investor Conference $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 9:31 AM on Monday, January 25th, 2021
  • The two-day event will feature presentations by eminent psychedelics companies and industry leaders
  • Novamind CEO and Director Yaron Conforti will present on Wednesday, January 27th at 9:55 AM EST

TORONTO, ON / January 25, 2021 / Novamind Inc. (CSE:NM) (“Novamind” or the “Company”), a mental health company specialized in psychedelic medicine, today announced the Company’s participation at the Psychedelics Investor Conference, hosted by KCSA Strategic Communications on Tuesday, January 26th and Wednesday, January 27th from 9:00 AM – 12:30 PM EST.

The two-day event will feature presentations by eminent psychedelics companies and industry leaders. Novamind CEO and Director Yaron Conforti will present on Wednesday, January 27th at 9:55 AM EST.

“We look forward to connecting with industry leaders and investors to discuss Novamind’s operating model for clinical care and clinical research in psychedelic medicine,” said Conforti.

Read more: https://agoracom.com/ir/Novamind/forums/discussion/topics/753850-novamind-to-present-at-inaugural-kcsa-psychedelics-investor-conference/messages/2300029#message

General Rick Hillier, Former Canadian Chief of the Defence Staff, to Lead KWESST $KWE.ca International Advisory Council $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 8:50 AM on Monday, January 25th, 2021
  • General (Retired) Rick Hillier will lead KWESST’s new International Advisory Council, which will provide guidance to the Company on its strategic build-out on a global scale.
  • General Hillier served as Canada’s Chief of Defence Staff (“CDS”) CDS from February 4, 2005, to July 1, 2008.
  • He is noted for “getting stuff done” and was instrumental in securing additional funding and modernized equipment for the Canadian military in support of Canada’s mission in Afghanistan.
  • In November 2020, Ontario Premier Doug Ford appointed General Hillier to oversee the province’s vaccination task-force in response to the COVID-19 pandemic.

Ottawa, Ontario–(January 25, 2021) – KWESST Micro Systems Inc. (TSXV: KWE) (“KWESST” or “the Company”) today announced that Canadian General (Retired) Rick Hillier will lead KWESST’s new International Advisory Council, which will provide guidance to the Company on its strategic build-out on a global scale. 

General Hillier served as Canada’s Chief of Defence Staff (“CDS”) CDS from February 4, 2005, to July 1, 2008. He is noted for “getting stuff done” and was instrumental in securing additional funding and modernized equipment for the Canadian military in support of Canada’s mission in Afghanistan. In November 2020, Ontario Premier Doug Ford appointed General Hillier to oversee the province’s vaccination task-force in response to the COVID-19 pandemic. 

KWESST Executive Chairman, David Luxton, commented that, “We are delighted and honoured that General Hillier, one of Canada’s most revered and universally respected Chiefs of Defence Staffs, has accepted this lead advisory role at KWESST, and we look forward to his wise counsel.”

Read More: https://agoracom.com/ir/Kwesst/forums/discussion/topics/753848-general-rick-hillier-former-canadian-chief-of-the-defence-staff-to-lead-kwesst-international-advisory-council/messages/2300025#message

ImagineAR $IP.ca $IPNFF Announces Partnership with BookYourStadium.com in Spain $DBO.ca $YDX.ca $SEV.ca $NTAR.ca

Posted by AGORACOM-JC at 7:49 AM on Monday, January 25th, 2021
http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg
  • Announced a partnership agreement with BOOK YOUR STADIUM www.bookyourstadium.com ) to deliver ‘one-of-a-kind’ AR experiences from historical soccer clubs in LaLiga ( Spain ) to fans around the world. 
  • The clubs which BOOK YOUR STADIUM is currently offering in the platform are REAL MADRIDCF , REAL SOCIEDAD CF , REAL VALLADOLID CF, VALENCIA CF, ATHLETIC CLUB CA OSASUNA , REAL BETIS BALOMPIÉ, and RC CELTA .
  • Throughout 2021, several national and international clubs are expected to join the platform.

VANCOUVER, BC and ERIE, Pa. , Jan. 25, 2020 – ImagineAR (IP:CSE) (IPNFF:OTCQB) an Augmented Reality company that enables sports teams, entertainers, brands and businesses to instantly create immersive global mobile phone AR campaigns, is excited to announce a partnership agreement with BOOK YOUR STADIUM www.bookyourstadium.com ) to deliver ‘one-of-a-kind’ AR experiences from historical soccer clubs in LaLiga ( Spain ) to fans around the world.  The clubs which BOOK YOUR STADIUM is currently offering in the platform are REAL MADRIDCF , REAL SOCIEDAD CF , REAL VALLADOLID CF, VALENCIA CF, ATHLETIC CLUB CA OSASUNA , REAL BETIS BALOMPIÉ, and RC CELTA . Throughout 2021, several national and international clubs are expected to join the platform.

Joaquín Martínez, CEO of BOOK YOUR STADIUM , states: ” We have developed a revolutionary online e-commerce fan engagement site and incorporated ‘best of breed’ innovative digital products. ImagineAR is a leader for sports fan AR engagement and we are going to partner on unique fan AR immersive experiences featuring top LaLiga soccer club players. Additionally, we are now an authorized ImagineAR partner to market their SDK platform to LaLiga clubs for integration into their existing mobile apps which are used by tens of millions of fans around the world.”

BOOK YOUR STADIUM www.bookyourstadium.com ), currently available in Spanish, is expected to be available in English in February 2021 and expand globally.   Initially, soccer fans can choose from over 200 experiences, adapted to the current health restrictions, to select from historical clubs in LaLiga. Some examples of experiences available include: access to virtual match experiences with exclusive content and games, e-sports matches with football players, Immersive AR experiences, virtual autographs, original match day events, or enjoy club lunch at home. In addition, there is the option of the SPORTBOX® , a themed gift box full of surprises with selected experiences from some clubs.

Read More: https://agoracom.com/ir/Imaginear/forums/discussion/topics/753838-imaginear-announces-partnership-with-bookyourstadium-com-in-spain/messages/2300007#message

Predictmedix Inc. $PMED.ca $PMEDF Provides Corporate Update

Posted by AGORACOM-JC at 7:44 AM on Monday, January 25th, 2021
Predictmedix Inc. (CSE: PMED | OTCQB: PMEDF) | LinkedIn
  • Initiatives and developments outlined below are in line with our larger goal of being the market leader in workplace health and safety by offering artificial intelligence powered technologies which address the major issues encountered in workplaces
  • Successfully deployed its technologies for beta testing purposes with major partners in North America and Asia, including India Oil (a fortune 500 corporation), MGM Hospital COVID-19 ward (one of the largest COVID-19 hospitals in Mumbai, India) and Flow Water.
  • Deployment at MGM Hospital is strategic to ensure our AI algorithms adapt to symptom associated changes brought on by new COVID-19 variants.
  • In other words, this allows our AI algorithm to adapt to the mutating virus.
  • Once learned, the technology is deployed immediately and is simultaneously functional across all present deployments.

TORONTO, Jan. 25, 2021 — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF)(“Predictmedix” or the “Company”) is pleased to provide a corporate update on its recent activities. This update will outline current progress, advancements of the Company and shed light on other corporate developments as the past few months have been about laying the groundwork for our long-term success. The initiatives and developments outlined below are in line with our larger goal of being the market leader in workplace health and safety by offering artificial intelligence powered technologies which address the major issues encountered in workplaces. 

Public showcase of our technology in New York City

Predictmedix and Juiceworks’ Safe Entry Station will be showcased in a Live event on Jan 26, 2021 in New York City by Wellness4Humanity.

Wellness4Humanity’s New York City (NYC) flagship location opens at 225 West 34th Street near Pennsylvania Station in the heart of Herald Square in the two-story high-impact space formerly occupied by Lane Bryant. The flagship location will be showcasing a Safe Entry Station powered by Predictmedix’s proprietary infectious disease symptom screening technology.

– Here is a link to a demo of our technology: https://www.youtube.com/watch?v=phziV7OBkjY

Read More: https://agoracom.com/ir/Predictmedix/forums/discussion/topics/753837-predictmedix-inc-provides-corporate-update/messages/2300006#message

$HPQ.ca Gen1 Nano Silicon Reactor Exceeds Expectations, Produces Sub 100 Nm Spherical #Nanopowders & #Nanowires $ENPH $BE $NNO.ca $PYR.ca

Posted by AGORACOM-JC at 8:18 AM on Thursday, January 21st, 2021

Low-Cost Manufacturing of Nano Silicon Materials

  • Gen1 NSiR system performance exceeded design and modelling expectations:
    • Successfully produced sub 100 nm silicon – based spherical nanopowders & nanowires.
    • Computer models suggested that the size limit of the material produced would be between 100 nm and 200 nm.SEM-XRD analysis indicates that the < 100 nm Si base spherical nanopowders & nanowires material could be used as anode material for Li-ion batteries, combined with graphite or not.

MONTREAL, Jan. 21, 2021 — Innovative silicon solutions provider HPQ Silicon Resources Inc. (“HPQ” or “the Company”) ( TSX-V: HPQ ; FWB: UGE ; Other OTC : URAGF ), through its wholly – owned subsidiary, HPQ Nano Silicon Powders inc (“HPQ NANO”), is pleased to update shareholders on milestones achieved during ongoing Gen1 PUREVAP TM Nano Silicon Reactor (“NSiR”) commissioning tests conducted by technology provider PyroGenesis Canada Inc. ( TSX: PYR ) .

“With the Gen1 PUREVAP TM NSiR operational and exceeding expectations from the start, HPQ NANO is uniquely positioned to be at the forefront of low-cost manufacturing of Nano Silicon for batteries and other applications, as we continue working on scaling up the capabilities of our PUREVAP TM NSiR process.” said Bernard Tourillon, President and CEO HPQ Silicon.

PUREVAP TM NSiR LOW-COST PROCESS: FIRST RESULTS ENCOURAGING, MORE TESTING TO FOLLOW

The material produced, under the less than optimum operating conditions of the first commissioning tests, was analysed by scanning electron microscope (SEM) imaging combined with X-ray diffraction (XRD) and yielded the following information:

  • Gen1 NSiR system performance exceeded design and modelling expectations:
    • Successfully produced sub 100 nm silicon – based spherical nanopowders & nanowires.
    • Computer models suggested that the size limit of the material produced would be between 100 nm and 200 nm.
  • SEM-XRD analysis indicates that the < 100 nm Si base spherical nanopowders & nanowires material could be used as anode material for Li-ion batteries, combined with graphite or not.
  • Samples from these commissioning tests have been sent to Professor Lionel ROUÉ of the Centre Énergie Matériaux Télécommunications (EMT) for electro-chemical evaluation.
  • Using results from data collected during these preliminary tests, PyroGenesis technical team has improved the design of the system and the operational parameters of the reactor.
    • It will be possible to provide further inputs and controls on the process to customize the composition and size of the spherical nano powders and nano wires.
  • The Gen1 NSiR is now ready to commence further testing of Silicon nano materials under new conditions, with a goal of producing larger size Silicon (Si) nanopowders and nanowires.

A METHODICAL APPROACH TO THE COMMERCIAL DEVELOPMENT OF OUR DISRUPTIVE TECHNOLOGY

Despite massive investment in Silicon material for batteries , current manufacturing processes are simply not scalable or commercially viable. The PUREVAP TM NSiR represents a game changing leap forward in resolving the issues of commercial viability and scalability, and with the Gen1 NSiR now operational, HPQ NANO is uniquely well positioned to offer industry participants a wide spectrum of products for testing.

The scale of the Gen1 PUREVAP TM NSiR allows HPQ NANO technical provider PyroGenesis to take full advantage of a quick R&D feedback loop during the testing phase. Over short periods, tests are completed, material produced is analysed by scanning electron microscope (SEM) imaging combined with X-ray diffraction (XRD), operational parameters are reviewed and system modifications and/or operational improvements are implemented. This is the key to our methodical approach of developing a truly disruptive low-cost technology that is going to change nano silicon materials manufacturing.

Tourillon added HPQ’s Silicon R&D consortium has the depth and flexibility to meet the challenges as we strive to produce products for renewable energy storage participants and electric vehicle manufacturers, who are searching for cost effective ways of increasing the Silicon contained in their batteries . Silicon’s potential to meet energy storage demand is undeniable, generating massive investments , and serious industry interest. We are very confident that the Silicon materials we are producing, with our expected low-cost scalable processes, will be in high demand by batteries, EV manufacturers and other participants in the ongoing renewable energy revolution.”

Read More: https://agoracom.com/ir/HPQ-SiliconResources/forums/discussion/topics/753558-hpq-gen1-nano-silicon-reactor-exceeds-expectations-produces-sub-100-nm-spherical-nanopowders-nanowires/messages/2299217#message

Victory Square Technologies $VST.ca $VSQTF Portfolio Company, Immersive Tech, Announces the Creation of World’s First #COVID-safe Location-Based Entertainment (LBE) Virtual Reality #VR Division “UNCONTAINED” $DBO.ca $YDX.ca $SEV.ca $NTAR.ca

Posted by AGORACOM-JC at 8:42 AM on Wednesday, January 20th, 2021
Victory Square Technologies | LinkedIn
  • Company launches first-ever COVID-safe location-based (LBE) Virtual Reality attractions division “UNCONTAINED” to disrupt the marketplace and fulfill demand from its Family Entertainment Center (FEC) clients.
  • Immersive Tech is planning for a public listing in the first half of 2021.
  • Leading immersive experience company builds upon current and past relationships with major companies.
  • Announcement brings creation of the world’s first-ever free-roam interactive VR franchise attraction available for rapid sale to the global attraction and entertainment marketplace.

VANCOUVER, British Columbia, Jan. 20, 2021 — Victory Square Technologies Inc. (“VST”) (CSE:VST) (OTC:VSQTF) (FWB:6F6) , a company that provides investors access to a diverse portfolio of companies in key sectors including: digital health, gaming, blockchain, AR/VR, cybersecurity, and cloud computing, is pleased to announce that its portfolio company Immersive Tech (“Company”) has launched a premiere new Location-Based Entertainment (LBE) VR attractions division named UNCONTAINED to capitalize on the growing demand for COVID-safe attractions. UNCONTAINED will be the world’s first free-roam interactive VR franchise attraction, built for a COVID world within shipping containers. The experience will allow for up to six players to roam freely within the container while interacting inside a digital environment as a team while making decisions that help guide and define the story.

Immersive Tech designs, engineers and builds custom technology-driven experiences, whether they facilitate brand integration or are aiming to create the best real life adventure possible. The Company recently announced the creation of three unique entertainment escape rooms custom designed and built for Apex Entertainment’s new location in Virginia Beach VA, USA. The three custom room themes include an underwater submarine adventure, a post-war bunker experience, and an AI-controlled warship gone rogue featuring a race against time and a family-friendly focus.

“UNCONTAINED” leverages the manner of design experience that Immersive Tech has gained and honed over the past four years in creating and launching highly successful interactive escape rooms for Family Entertainment Centers. This is complemented by a fundamental understanding of shipping containers as highlighted in their recent 3-room escape experience for Leaps by Bayer, a Bayer Pharmaceutical company, in 2020.

Read More: https://agoracom.com/ir/VictorySquareTechnologies/forums/discussion/topics/753450-victory-square-technologies-portfolio-company-immersive-tech-announces-the-creation-of-world-s-first-covid-safe-location-based-entertainment/messages/2299018#message

Kontrol $KNR $KNR.ca $KNR.c $KNRLF Advances BioCloud Technology for European Sales and Provides Update $SNE $MSFT $HON $GOOGL $QCOM

Posted by AGORACOM-JC at 7:48 AM on Wednesday, January 20th, 2021
kontrol-logo
  • Announced that it continues to advance the deployment of its BioCloud technology
  • Initiated the CE standards approval process and BioCloud now has the appropriate power supply ratings for European applications
  • In the process of establishing a viral/pathogen advisory committee that will work with management to accelerate various BioCloud applications
  • “We are pleased with the progress we are making with our distribution network, our direct customers and various levels of Government,” says Paul Ghezzi, CEO. “Through our growing distribution network, we have been presented with numerous potential customers applications. Most recently we have reviewed various applications for professional and amateur sports.”

TORONTO, ON / January 20, 2021 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“), a leader in smart buildings and cities through IoT, Cloud and SaaS technology, is pleased to announce that it continues to advance the deployment of its BioCloud technology.

“We are pleased with the progress we are making with our distribution network, our direct customers and various levels of Government,” says Paul Ghezzi, CEO. “Through our growing distribution network, we have been presented with numerous potential customers applications. Most recently we have reviewed various applications for professional and amateur sports.”

Non-Disclosure Agreement (NDA)

BioCloud has entered into a Non-Disclosure Agreement, with a leading medical sports authority, to share the full scope of BioCloud’s patents and research. The purpose of the NDA is to advance various potential sport applications. Such applications include, but are not limited to, dressing rooms and training facilities.

BioCloud European Standards

Kontrol has initiated the CE standards approval process and BioCloud now has the appropriate power supply ratings for European applications, which is an important prerequisite for European sales. As part of the product requirements for each country within the European Union there may be further standards approval required but these will be dealt with on a case-by-case basis.

Distribution Network

Kontrol has recently added a South Korean firm to its growing distribution network and is in discussion with numerous interested parties.

Viral/Pathogen Advisory Committee

Kontrol is in the process of establishing a viral/pathogen advisory committee that will work with management to accelerate various BioCloud applications. Kontrol seeks to establish the committee in February 2021.

Corporate Name Change

Kontrol’s corporate name change to Kontrol Technologies Corp. is anticipated to be completed by the end of January 2021. There has been no specific delay in the process other than the time it takes to complete filings between B.C. and Ontario corporate registries and all of the associated requirements.

About Kontrol BioCloudTM

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others. Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com

BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus). Safe Space Technology is a Kontrol Trademark.

Read More: https://agoracom.com/ir/KontrolEnergy/forums/discussion/topics/753445-kontrol-advances-biocloud-technology-for-european-sales-and-provides-update/messages/2299011#message

VIDEO – Valeo Pharma $VPH.ca $VPHIF Starts Off 2021 With A Bang As MDBriefcase Validates Key Ingredients In Its Immune System Support Product $HLS.ca $MDP.ca $GUD.ca $RX.ca

Posted by AGORACOM-JC at 5:57 PM on Tuesday, January 19th, 2021
Valeo Pharma (@valeo_pharma) | Twitter

Valeo Pharma is already a successful, revenue generating, small cap Canadian pharmaceutical company that acquires the Canadian rights to commercialized drugs in other parts of the world that don’t have Canada on their radar as a target market.

This “in-license” business model is ingenious because it means ZERO developmental or clinical risk, which is the downfall of most small cap pharma companies. 

This model has resulted in the following success:

  • $5.3M in revenues in the first 9 months of 2020 (ending July 31, 2020)
  • 9 products currently in the market with an annual estimated peak sales of $40M/year
  • 7 products in the pipeline with an annual estimated peak sales of $45M/year

In fact, capital markets confidence is so high that Valeo secured $8.6M in financing in the last half of the year with:

  • $6.9M Bought Deal financing at $1.20/shares
  • A $1.7M Oversubscribed debenture (non-convertible) 

If that was all Valeo had, most investors would be happy to sit back and watch the Company grow.

But then came Redesca.  We are going to save you the science and tell you that Redesca belongs to a class of anticoagulant medications (blood thinners) called LMWH.  The size of the Canadian LMWH market is over $200M per year and Valeo believes they can capture 15-30% of this market.  If you’re doing back of napkin math, that equates to $30,000,000 – $60,000,000 per year in revenues.

But how does a new product capture that much market share?  Glad you asked because we asked CEO Steve Saviuk the same question.  Competition is tough in all markets and they don’t let someone take 15-30% market share without one hell of a fight. 

Saviuk agreed and gave the following reasons:

1.  Redesca has an 8-year international track record of safety and efficacy.  It is already well known

2. Redesca is flat out cheaper, which is music to the ears of Provincial Health Ministries whose budgets have been stretched to the max this year no thanks to COVID-19.  

Vaelo is so confident that it stated “This is great news for the Canadian healthcare system …. and is expected to help provide significant savings to provincial healthcare systems.”

Well there you have it.  Valeo is a great story. Watch the video.

HOLD ON. THERE’S MORE … A LOT MORE

In a recently issued newsletter by MDBriefCase entitled “Exploring Novel Therapeutic Approaches for Covid-19: Hesperidin vs Vitamin C” the newsletter stated that recently accumulated evidence suggests that Hesperidin supplementation may be useful as a prophylactic agent against SARS-Cov-2 infection and as a complementary treatment during COVID-19 disease.  What does this mean?

  • Growing body of research suggests Hesperidin may interfere with SARS-CoV-2 infection process
  • Hesperidin may help against Covid-19 viral replication
  • Hesperidin is a potent antioxidant with anti-inflammatory activity that may help in controlling cytokine storm (where the body starts to attack its own cells and tissue rather than just the virus)
  • Valeo’s unique Hesperidin formulation (HESPERCO) is the only format available where every capsule contains 500mg of concentrated Hesperidin.

Now you have it.  That’s the Valeo story as it applies to just 2 of their amazing products.  There is a whole lot more to the story given their pipeline of products but we couldn’t cover it all in this great interview with CEO Steve Saviuk.

If you love revenue generating, growing and blue sky potential small cap companies, then this Valeo interview is a must watch.

Victory Square $VST.ca $VSQTF Technologies Signs Binding Letter of Intent to Acquire IV Hydreight, An On-Demand & On-Site Mobile #Health, #Pharmaceutical & #Wellness Service Provider Across the United States $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 9:19 AM on Tuesday, January 19th, 2021
Victory Square Technologies | LinkedIn
  • Hydreight provides a completely compliant turnkey business model for health professionals to offer fully licensed medical, health & wellness services through an on-demand and on-site platform.

  • In addition to providing telehealth services, Hydreight also provides a diverse suite of health & wellness protocols that include IV drip, Botox, COVID-19 testing, and other medical and medispa treatments.

  • Hydreight is a USA certified e-script and telemedicine provider, allowing Hydreight to offer a wide array of health and medical services in all 50 states.

  • Hydreight provides full pharmaceutical offerings across the United States (Hydreight has full 503B Pharmaceutical supply capabilities ).
  • Hydreight has established key relationships and supply network chains with major vendors including: Medline, Mckesson, Allergan (Botox), Galderma and numerous pharmacies.

VANCOUVER, British Columbia, Jan. 19, 2021 — Victory Square Technologies Inc. (” Victory Square ” or the “ Company ”) (CSE:VST) (OTC:VSQTF) (FWB:6F6), a company that provides investors access to a diverse portfolio of companies in key sectors including: digital health, gaming, blockchain, AR/VR, cybersecurity, and cloud computing, is pleased to announce that it has signed a binding letter of intent (the “ LOI ”) dated January 13, 2021 in respect of the acquisition (the “ Acquisition ”) of all of the shares of IV Hydreight Inc. (“ Hydreight ”), a mobile health and wellness service provider operating in the United States.

Founded in 2018, Hydreight provides a unique, custom built, proprietary telemedicine service that allows users to book confidential health & wellness and/or medical services at their home, hotel, office or wherever they may need discreet assistance. The business model of Hydreight leverages decentralized healthcare to bring quality telehealth, medical, health and wellness services to the masses in an efficient, scalable and cost effective way.

Read More: https://agoracom.com/ir/VictorySquareTechnologies/forums/discussion/topics/753355-victory-square-technologies-signs-binding-letter-of-intent-to-acquire-iv-hydreight-an-on-demand-on-site-mobile-health-pharmaceutical-wellness/messages/2298763#message